Replies to post #252655 on Avid Bioservices Inc (CDMO)

[biopharm]

..I've touched before on BergenBio but I find all this fascinating... and when did PPHM seem to have those back to back days of 30M shares was it? that just so happened in March of 2014 and this was about the time that ex-PPHM Longhen Zhou went from BerGenBio back over to NantBioscience (part of Nantworks..) but heck, what isn't part of Nantworks so many divisions over there.
...
..

I wouldn't want anyone to forget that Longhen Zhou was also part of the 11 authors below... CALICO is falling fast off of my initial favorites list to come on board and steer SS Peregrine right past other BP's... what a puzzle we have here : )

Luhrs and Parseghian...interesting duo and just so happened to notice that Parseghian has recent work with 11 authors and one of them at Peregrine ... hmmmmmm...

Pfizer and Allergan and ??? coming soon after Peregrine ? ... but then we have Zhou from Nant Bioscience owned by Patrick Soon-Shiong and hell... maybe they need a few big backers in order to afford to get a stake in Peregrine Pharmaceuticals

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=118661335&txt2find=brigitte|phan|patent

[biopharm]

I've touched before on BergenBio but I find all this fascinating... and when did PPHM seem to have those back to back days of 30M shares was it? that just so happened in March of 2014 and this was about the time that ex-PPHM Longhen Zhou went from BerGenBio back over to NantBioscience (part of Nantworks..) but heck, what isn't part of Nantworks so many divisions over there.

Nice pipeline BerGenBio has...
http://www.bergenbio.com/pipeline/

Wonder if the CSO agrees with Rolf Brekken and PS Targeting

James Lorens
http://www.bergenbio.com/about-us/management-team/

Day 2: Wednesday May 11, 2016
Chair: Jim Lorens

Rolf Brekken:
Phosphatidylserine signaling and immune suppression in the tumor
microenvironment


http://www.uib.no/sites/w3.uib.no/files/attachments/program_-_ccbio_symposium_2016_4.0_prefinal.pdf

so much more going on within the next 30 days that some just fail to take notice on......

Ask yourself why Rolf is seeked out to present and speak with James Lorens as Chair of this conference and BerGenBio ... hmmmm, we've touched on them several times before....

If James Loren and Rolf Brekken lead in certain directions.... I bet 100% that the pipeline of BerGenBio would be helped by PS Targeting

PS Targeting being pulled in all sorts of directions I bet as well, especially with a lot of $250 Million falling in the hands of Jedd Wolchok @MSK

10 trading days or so... before Peregrine Pharmaceuticals stock options are set at such an interesting level for the next 6 months. Things sure can change quick in a hurry round here.

I imagine there are a few other presentations being prepared for as well....that are also not on the schedule... yet...hmmmm